IL107232A - 19, 11-bridged 4-estrene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same - Google Patents

19, 11-bridged 4-estrene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same

Info

Publication number
IL107232A
IL107232A IL107232A IL10723293A IL107232A IL 107232 A IL107232 A IL 107232A IL 107232 A IL107232 A IL 107232A IL 10723293 A IL10723293 A IL 10723293A IL 107232 A IL107232 A IL 107232A
Authority
IL
Israel
Prior art keywords
benzo
lla
dihydro
hydroxy
dione
Prior art date
Application number
IL107232A
Other languages
English (en)
Other versions
IL107232A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL107232A0 publication Critical patent/IL107232A0/xx
Publication of IL107232A publication Critical patent/IL107232A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Glass Compositions (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Investigation Of Foundation Soil And Reinforcement Of Foundation Soil By Compacting Or Drainage (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Eye Examination Apparatus (AREA)
  • Toys (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL107232A 1992-10-13 1993-10-11 19, 11-bridged 4-estrene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same IL107232A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4235220A DE4235220A1 (de) 1992-10-13 1992-10-13 Gestagen wirksame 19,11ß-überbrückte 4-Estrene

Publications (2)

Publication Number Publication Date
IL107232A0 IL107232A0 (en) 1994-01-25
IL107232A true IL107232A (en) 1998-06-15

Family

ID=6470806

Family Applications (1)

Application Number Title Priority Date Filing Date
IL107232A IL107232A (en) 1992-10-13 1993-10-11 19, 11-bridged 4-estrene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same

Country Status (25)

Country Link
US (2) US5523298A (cs)
EP (1) EP0664811B1 (cs)
JP (1) JP3302366B2 (cs)
KR (1) KR100341066B1 (cs)
CN (1) CN1052238C (cs)
AT (1) ATE156837T1 (cs)
AU (1) AU677019B2 (cs)
BR (1) BR9307232A (cs)
CA (1) CA2146962A1 (cs)
CZ (1) CZ284187B6 (cs)
DE (2) DE4235220A1 (cs)
DK (1) DK0664811T3 (cs)
ES (1) ES2108298T3 (cs)
FI (1) FI951760A0 (cs)
GR (1) GR3024940T3 (cs)
HU (1) HU223315B1 (cs)
IL (1) IL107232A (cs)
NO (1) NO305440B1 (cs)
NZ (1) NZ256865A (cs)
PL (1) PL179764B1 (cs)
RU (1) RU2157814C2 (cs)
SK (1) SK280991B6 (cs)
TW (1) TW341575B (cs)
WO (1) WO1994009025A1 (cs)
ZA (1) ZA937614B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4235220A1 (de) * 1992-10-13 1994-06-16 Schering Ag Gestagen wirksame 19,11ß-überbrückte 4-Estrene
DE4413185A1 (de) * 1994-04-12 1995-10-19 Schering Ag 11beta,19-überbrückte 13alpha-Alkylsteroide
DE4413184A1 (de) * 1994-04-12 1995-10-19 Schering Ag 10,11-C¶3¶-überbrückte Steroide
US5912006A (en) * 1996-08-28 1999-06-15 Eboc, Inc. Compositions and methods for alleviating discomforting menstrual pain
EP1373888A2 (en) * 2000-12-28 2004-01-02 Schering Aktiengesellschaft Method for screening for progesterone receptor isoform-specific ligands
US20040121304A1 (en) * 2001-12-21 2004-06-24 Ulrike Fuhrmann Method for screening for progesterone receptor isoform-specific ligands and for tissue-selective progesterone receptor ligands
GB0219345D0 (en) * 2002-08-20 2002-09-25 Givaudan Sa Improvements in or relating to organic compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU139639A1 (ru) * 1960-03-28 1960-11-30 Н.В. Маревич Крепь дл поддержани междуэтажных целиков при щитовой системе разработки
US3465010A (en) * 1966-11-22 1969-09-02 Searle & Co 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof
US4361559A (en) * 1981-08-20 1982-11-30 E. R. Squibb & Sons, Inc. Antiinflammatory 17,17-bis (substituted thio) androstenes
DE3708942A1 (de) * 1987-03-18 1988-09-29 Schering Ag 19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
US5446178A (en) * 1987-03-18 1995-08-29 Schering Aktiengesellschaft Process for preparing 19,11β-bridged steroids
DE3717169A1 (de) * 1987-05-19 1988-12-01 Schering Ag 19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3832303A1 (de) * 1988-09-20 1990-04-12 Schering Ag 11ss-phenyl-14ssh-steroide
DE3917274A1 (de) * 1989-05-24 1990-11-29 Schering Ag 9(alpha)-hydroxy-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE4038128A1 (de) * 1990-11-27 1992-06-04 Schering Ag 8-en-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE4235220A1 (de) * 1992-10-13 1994-06-16 Schering Ag Gestagen wirksame 19,11ß-überbrückte 4-Estrene

Also Published As

Publication number Publication date
AU677019B2 (en) 1997-04-10
NO305440B1 (no) 1999-05-31
TW341575B (en) 1998-10-01
NO951444L (no) 1995-06-13
RU2157814C2 (ru) 2000-10-20
BR9307232A (pt) 1999-08-24
EP0664811A1 (de) 1995-08-02
DE4235220A1 (de) 1994-06-16
ES2108298T3 (es) 1997-12-16
US5523298A (en) 1996-06-04
IL107232A0 (en) 1994-01-25
PL179764B1 (pl) 2000-10-31
SK280991B6 (sk) 2000-10-09
ZA937614B (en) 1994-05-23
FI951760A7 (fi) 1995-04-12
FI951760L (fi) 1995-04-12
HU9501057D0 (en) 1995-06-28
CZ284187B6 (cs) 1998-09-16
GR3024940T3 (en) 1998-01-30
HU223315B1 (hu) 2004-05-28
NO951444D0 (no) 1995-04-12
DE59307133D1 (de) 1997-09-18
JPH08502276A (ja) 1996-03-12
WO1994009025A1 (de) 1994-04-28
RU95109891A (ru) 1997-02-10
CA2146962A1 (en) 1994-04-28
ATE156837T1 (de) 1997-08-15
HUT71523A (en) 1995-12-28
FI951760A0 (fi) 1995-04-12
SK49495A3 (en) 1995-08-09
DK0664811T3 (da) 1998-03-30
CZ91995A3 (en) 1995-09-13
CN1092428A (zh) 1994-09-21
EP0664811B1 (de) 1997-08-13
CN1052238C (zh) 2000-05-10
US5703066A (en) 1997-12-30
KR950703576A (ko) 1995-09-20
NZ256865A (en) 1996-04-26
KR100341066B1 (ko) 2002-12-06
PL308349A1 (en) 1995-07-24
JP3302366B2 (ja) 2002-07-15
AU5177493A (en) 1994-05-09

Similar Documents

Publication Publication Date Title
KR20100017780A (ko) 17베타-시아노-18ａ-호모-19-노르-안드로스트-4-엔 유도체, 그의 용도, 및 상기 유도체를 함유하는 의약
JP2003515543A (ja) １４，１５−ベータ−メチレン置換されたアンドロゲン
KR20100028554A (ko) 17β-시아노-19-노르-안드로스트-4-엔 유도체, 그의 용도, 및 상기 유도체를 함유하는 의약
US5523298A (en) Progestationally active 19,11-bridged 4-estrenes
AU2008266526A1 (en) Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation
AU2008263857A1 (en) 17beta-cyano-19-androst-4-ene derivative, use thereof and medicaments containing said derivative
SK78897A3 (en) 14'alpha',17'alpha'-c2-bridged 19-nor-progesterone derivatives, pharmaceutical composition containing the same and intermediate products for producing the same
JP5600069B2 (ja) １７−（１’−プロペニル）−１７−３’−オキシドエストラ−４−エン−３−オン誘導体、その使用及び当該誘導体を含む医薬品
AU2008342910A1 (en) 17-hydroxy-19-nor-21-carboxylic acid-steroid gamma-lactone derivative, use thereof, and medicament containing the derivative
KR20100094999A (ko) １５,１６-메틸렌-１７-히드록시-１９-노르-２１-카르복실산 γ-락톤 유도체, 그의 용도 및 상기 유도체를 함유하는 의약
KR100730010B1 (ko) 신규 안드로겐
HK1141537A (en) 17β-CYANO-19-ANDROST-4-ENE DERIVATIVE, USE THEREOF AND MEDICAMENTS CONTAINING SAID DERIVATIVE
WO1995027725A1 (de) 11β,19-ÜBERBRÜCKTE 13α-ALKYLSTEROIDE
WO1995011915A1 (de) 10,11β-C2-ÜBERBRÜCKTE STEROIDE
HK1141535A (en) 17β-CYANO-19-NOR-ANDROST-4-ENE DERIVATIVE, USE THEREOF AND MEDICAMENTS CONTAINING SAID DERIVATIVE
HK1151532A1 (en) 19-NOR-STEROID DERIVATIVES WITH A 15α,16α-METHYLENE GROUP AND A SATURATED 17,17-SPIROLACTONE RING, USE THEREOF, AND MEDICAMENTS CONTAINING SAID DERIVATIVES
WO1995027726A1 (de) 10,11-c3-überbrückte steroide
HK1151532B (en) 19-NOR-STEROID DERIVATIVES WITH A 15α,16α-METHYLENE GROUP AND A SATURATED 17,17-SPIROLACTONE RING, USE THEREOF, AND MEDICAMENTS CONTAINING SAID DERIVATIVES
DE19535851A1 (de) 18-Norsteroide mit gestagener Wirkung
HK1151801B (en) 15,16-METHYLENE-17-HYDROXY-19-NOR-21-CARBOXYLIC ACID γ-LACTONE DERIVATIVE, USE THEREOF, AND MEDICAMENT CONTAINING SAID DERIVATIVE

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
RH1 Patent not in force